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Peter Collignon and colleagues1 
aim to improve understanding of 
global antibiotic resistance drivers 
by quantifying associations be­
tween antibiotic resistance and 
potential contributing factors. A 
recent systematic review including 
565 studies primarily reporting 
patient­level data found that anti­
biotic exposure, underlying disease, 
and invasive procedures had the 
greatest evidence of being antibiotic 
resistance drivers. 2 Given the 
small evidence base for the role of 
community factors,2 we fully concur 
with Collignon and colleagues about 
the importance of considering such 
factors in the spread of antibiotic 
resistance.1 However, as the authors 
recognise, correlation does not imply 
causation—indeed, national meticillin­
resistant Staphylococcus aureus rates 
strongly correlate with unfair play of 
national football teams.3 Conversely, 
it would be a mistake to conclude that 
weak (or even inverse) correlation 
between antibiotic use and antibiotic 
resistance at the national level 
implies an absence of a strong causal 
relationship (appendix).
There are several limitations to using 
current global data. First, important 
between­country differences in the 
quality and representativeness of 
data are likely to exist. For example, 
blood cultures are less frequently 
taken in resource­poor settings than 
in resource­rich settings, and often 
only when patients do not respond to 
empirical therapy, leading to inflated 
estimates of resistance.4 Moreover, in 
lower income countries, a substantial 
proportion of antibiotics used might 
come from informal providers and 
not appear in consumption data. 
Both factors would be expected to 
weaken associations between reported 
antibiotic use and resistance, and could 
lead to positive associations between 
governance and infrastructure and 
antibiotic resistance, even if these 
factors have no effect on antibiotic 
resistance.
Additionally, comparisons based on 
national­level data can be problematic, 
particularly when many countries have 
a sharp divide be tween subpopulations 
that overuse anti biotics and those that 
are without access. Patients lacking 
access to antibiotics are also less likely 
to have access to health­care facilities 
where blood samples are taken. 
Considering antibiotic consumption 
only on a national per capita basis 
could therefore considerably under­
estimate antibiotic consumption in 
sub pop u lations where resistance is 
being measured. Using a multivariable 
model will unfortunately not 
overcome such biases.
Finally, the analysis simplifies anti­
biotic use such that the matter of 
which antibiotic is consumed is 
not considered, which will have 
importance in terms of resistance 
development.5 Combined antibiotic 
consumption measures might 
therefore not be optimal for 
determining the contribution of 
antibiotic consumption to resistance.
While we welcome the central 
conclusion of the study about 
the need for efforts to reduce the 
spread of antibiotic resistance in the 
community, we are concerned that 
fundamental limitations of the data 
could have led to an undervaluing of 
the role of antibiotic stewardship.
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